HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box - Wikidata - wikimedia - TriplyDB

HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box

HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box

http://www.wikidata.org/entity/Q28271374

about

Olfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cells Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development Thymine DNA glycosylase represses myocardin-induced smooth muscle cell differentiation by competing with serum response factor for myocardin binding Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes Histone deacetylase activity selectively regulates notch-mediated smooth muscle differentiation in human vascular cells.Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis.Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells.Modulation of myocardin function by the ubiquitin E3 ligase UBR5.Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation.MicroRNAs dynamically remodel gastrointestinal smooth muscle cells Expression of Foxm1 transcription factor in cardiomyocytes is required for myocardial development.Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention.An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation.Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2.Alcohol and cardiovascular disease--modulation of vascular cell function.Alcohol inhibits smooth muscle cell proliferation via regulation of the Notch signaling pathway Vascular smooth muscle progenitor cells: building and repairing blood vessels.Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krüppel-Like Factor 4 (AMPK/KLF4) Signaling Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling.Notch transcriptional control of vascular smooth muscle regulatory gene expression and function.Delta-Notch--and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors Notch signaling in the vasculature Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall re Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin.Arp5 is a key regulator of myocardin in smooth muscle cells Signaling mechanisms that regulate smooth muscle cell differentiation.Molecular pathways of notch signaling in vascular smooth muscle cells.Transgelins, cytoskeletal proteins implicated in different aspects of cancer development.Smooth Muscle Cell Differentiation: Model Systems, Regulatory Mechanisms, and Vascular Diseases.Mesenchymal stem cells and vascular regeneration.Notch Signaling in Vascular Smooth Muscle Cells.Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma.Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.Repression of smooth muscle differentiation by a novel high mobility group box-containing protein, HMG2L1.Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.

P2860

e8bc7715d62c03840a2376aa2e5aad180f9b5e35

P248

Q24305366-97358376-FE15-4FD8-8FE7-8E42749F38EF Q24309221-A3421E1F-A68C-4EE7-B797-CA1C732AC12E Q28267098-15294B18-C6E3-45EF-88AC-5122729CAE37 Q28581191-C751E74A-210C-4B59-9E13-EF8ABB82E96C Q28589105-4567D54A-86CD-4F86-9083-85BBD32E01A1 Q29347238-953F4CAD-26C1-40FD-84A6-50962A9E353F Q30424133-CB3BFB51-4BE4-45BB-8489-465C5D879FF0 Q30436555-C362AC2E-354C-47DC-9BFB-7429600125D7 Q30440082-73308F8A-2D2E-4BE8-86F8-92601CA0B6AC Q30441514-C3530373-8E69-4B7F-BC16-7F8BCFEB0830 Q33782403-56E67A48-C3FE-4A3A-9743-C36E748CF3C2 Q33885162-A8B60BA2-1F0B-4418-ADF8-9FCB56FE1992 Q33886565-9AFF69A8-2D7D-4662-A661-BCCB5938619A Q33968310-9E5861B6-CF6D-4CE7-B12C-5010B0C8067F Q34146262-CC36C62E-900C-492C-BB44-2F370901128F Q34516783-E08CAC98-1665-433C-A6E5-D3A231B47B50 Q34608845-106846CA-34C3-4DAD-9B1E-8F9420163517 Q34889421-A068FF21-7EC2-4905-831F-3F4A55E17990 Q35942603-0F56DAD4-758A-462F-B124-35E445B093AE Q36021912-317DF1AF-EE99-449C-A36E-8AE3F7338965 Q36055604-C19C5CEC-EE22-4431-87D3-10D65ACFE7EF Q36203076-623BDF9D-B197-4BB4-94E1-016FD5BA4A41 Q36548425-406C32D4-6D6D-4097-B8D6-A0FB9A44D9B9 Q36779521-6B603F20-5AE2-4259-8AA7-80801A99C5FC Q36857288-D3581B89-909B-45C6-8517-96CDD892C773 Q36861805-962A623D-AD2F-4778-B372-B2C2C7A26371 Q37048514-FE12EFA1-9E23-43ED-9E25-344A12FEE831 Q37546984-847365DD-320E-4EC4-A4D5-D0EC465C224A Q37614849-3305D94F-6600-4C6C-B0D4-A82F0510A77B Q37890184-3FC25B7F-6DE0-416F-B59A-FC4F65B47C2F Q38003146-4FFFAA70-DDFE-476C-B766-F756AD92C3D9 Q38183143-2F038ACD-A324-4C05-AEBC-18F734295BDE Q38596550-9540100F-6A04-49C4-9520-3D2AEAD0924F Q38816740-F126C982-AE88-492E-85AE-10964E984F70 Q39141059-6DA9C475-FE5C-408C-AEC9-643697B21D3F Q39563180-1BF7FBB1-5D9F-4FD8-BF50-AB0C033D1EC0 Q39654774-3F293D83-A142-4638-BBCA-AA60F2AF28CC Q39673967-BFD42E22-2877-4731-97B1-EE319532C3B5 Q39698789-E22DDF51-8CB5-4AFB-96D8-5779BE2C17B7 Q40044363-703830E8-65C0-42AB-A3B9-86D51BDDB8D8

P2860

HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box

http://www.wikidata.org/entity/Q28271374

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@ast

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@en

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@nl

type

label

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@ast

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@en

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@nl

prefLabel

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@ast

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@en

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@nl

P1433

Q28271374-9904C5F6-EEEA-406B-BBC9-9999FF4BAE06

P1476

Q28271374-34079E47-8D68-4011-AA19-DAEBD4E31B94

P2093

Q28271374-05A1BFE6-6597-484B-88E9-F6851B34B22F

Q28271374-110DFF55-3BBC-4C39-A257-9D3DDB8EEAE1

Q28271374-2D531EC3-A716-4F4C-A326-44848E2AFF55

Q28271374-3EFA66B7-0597-4818-8570-BFA26BBD7139

Q28271374-4ADED6A1-211F-4F98-ABD9-19CA48C605EB

Q28271374-5DEA5ACA-6DEE-42CF-BF54-89455C34B06E

Q28271374-6CDBBA34-21C9-4C4C-A780-D898D34C6712

Q28271374-98168359-8806-442E-858C-D0B1EC117FBD

Q28271374-A3A1F600-EE6E-4D4B-9B91-F7A0C6B54871

Q28271374-A528AF33-0126-4CFF-8467-CE7F1F26372B

P304

Q28271374-8FB273DA-7D76-4C04-BFEF-D6FCF1F02D0A

P31

Q28271374-CBA47B6B-D30F-4611-ABD8-56B03CF88B06

P356

Q28271374-3D35FB1C-9379-497F-9EC0-0F7A1F3C30DA

P407

Q28271374-3770DE56-5963-4BE9-8C0C-2E75DD3C24DC

P433

Q28271374-EE131653-B7FC-4E50-929C-91554858B1D2

P478

Q28271374-F018AAE4-3B66-42AC-9653-15D789CFCF8F

P577

Q28271374-C2832613-5F71-4960-8DA0-E92C84A7AB6B

P698

Q28271374-DF530C61-0FBD-4E4F-93A2-93256A4DFBBE

P921

Q28271374-48E53C3F-1938-4F07-A655-D580C7F57B4B

Q28271374-ECF38CA8-8C69-46F1-ADD9-7543CFB71228

P356

01.ATV.0000185829.47163.32

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

HERP1 inhibits myocardin-induc ...... g with SRF binding to CArG box

@en

P2093

Ei-ichi Okamoto

http://www.w3.org/2001/XMLSchema#string

Hideo Akiyama

http://www.w3.org/2001/XMLSchema#string

Hiroko Sato

http://www.w3.org/2001/XMLSchema#string

Hiroshi Doi

http://www.w3.org/2001/XMLSchema#string

Hiroyoshi Kanai

http://www.w3.org/2001/XMLSchema#string

Keiko Kawai-Kowase

http://www.w3.org/2001/XMLSchema#string

Larry Kedes

http://www.w3.org/2001/XMLSchema#string

Masahiko Kurabayashi

http://www.w3.org/2001/XMLSchema#string

Masashi Arai

http://www.w3.org/2001/XMLSchema#string

Miki Yamazaki

http://www.w3.org/2001/XMLSchema#string

P304

2328-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.ATV.0000185829.47163.32

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16151017

http://www.w3.org/2001/XMLSchema#string

P921

vascular smooth muscle cell differentiation